[Efficacy of selective bronchial occlusion in the treatment of intractable pneumothorax].

医学 气胸 治愈率 耐火材料(行星科学) 外科 病历 内科学 天体生物学 物理
作者
Lisong Lin,X Y Chen,Hailin Zhang,Y F Chen,Y X Zhang,Yiming Zeng
出处
期刊:PubMed [National Institutes of Health]
卷期号:102 (44): 3501-3504
标识
DOI:10.3760/cma.j.cn112137-20220708-01510
摘要

Objective: To analyze the effect of selective bronchial occlusion (SBO) in the treatment of intractable pneumothorax. Methods: A total of 86 patients with refractory pneumothorax treated with SBO in the Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Fujian Medical University from January 1, 2019 to December 31, 2021 were included in this study. The basic information, diagnosis and treatment of the patients were collected and analyzed based on their inpatient records. Results: The age of the subjects was (62±11) years old, and 83 cases (96.5%) were male. The first time SBO cure rate was 30.2% (26/86). The effective rate of the first time SBO treatment was 38.4% (33/86), and the final cure rate of SBO was 59.3% (51/86). The total cure rate of SBO combined with other therapies was 73.3% (63/86). The median time [M (Q1, Q3)] from the first plugging to the complete cessation of air leakage in SBO cured patients was 6.5 (3, 7) days, which was shorter than that in the final extubation patients after SBO [11 (7, 19) days] (H=30.24, P<0.001). The median [M (Q1, Q3)] length of hospital stay of the first SBO cured patients was 19 (14, 25) days, which was shorter than that of all patients [28 (19, 37) days] (H=12.89, P=0.002). The median [M (Q1, Q3)] hospitalization expenses of patients with first SBO cure, effective SBO treatment and ineffective SBO treatment were 23 187 (18 906, 27 798), 41 580 (29 388, 50 762) and 38 462 (27 542, 51 720) yuan, respectively, and the difference was statistically significant (H=18.58, P<0.001). The incidence of complications after SBO was 7.59% (11/145). Conclusion: SBO has good efficacy and relative high safety in the treatment of intractable pneumothorax.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
李健的应助被山竹里采纳,获得10
刚刚
wangxuan完成签到,获得积分10
1秒前
1秒前
MAX完成签到 ,获得积分10
3秒前
Eric发布了新的文献求助30
3秒前
等待戈多发布了新的文献求助10
3秒前
000发布了新的文献求助10
4秒前
清河聂氏完成签到,获得积分10
5秒前
Maestro_S的应助被UGO采纳,获得10
5秒前
卡比兽mini完成签到 ,获得积分10
6秒前
舒心聪展完成签到,获得积分10
6秒前
CHRIS完成签到,获得积分10
8秒前
黎黎发布了新的文献求助10
8秒前
000完成签到,获得积分10
9秒前
天天完成签到,获得积分10
9秒前
lll完成签到 ,获得积分10
10秒前
adapt发布了新的文献求助30
11秒前
朴素旭尧完成签到,获得积分10
11秒前
Hello的应助被lq采纳,获得10
11秒前
心想事成完成签到 ,获得积分10
12秒前
12秒前
Doraemon-2077发布了新的文献求助10
12秒前
受伤的菠萝完成签到,获得积分10
12秒前
yang2pu完成签到,获得积分10
13秒前
酷炫雁荷完成签到 ,获得积分10
14秒前
张淞鑫完成签到,获得积分10
16秒前
pingpinglver发布了新的文献求助10
17秒前
Cakoibao的应助被精明怜南采纳,获得10
17秒前
科研通AI6.3的应助被灵巧绿海采纳,获得30
17秒前
17秒前
18秒前
lyk2815完成签到,获得积分10
19秒前
xiong完成签到,获得积分10
19秒前
20秒前
Nana完成签到 ,获得积分10
20秒前
21秒前
小猫完成签到 ,获得积分10
21秒前
氮源完成签到 ,获得积分10
21秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190410
求助须知:如何正确求助?哪些是违规求助? 9577638
关于积分的说明 21853499
捐赠科研通 7789404
什么是DOI,文献DOI怎么找? 3436395
关于科研通互助平台的介绍 2560220
邀请新用户注册赠送积分活动 2483032